Bio Report

PODCAST: 2/16/2023

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

The microbial world has been a rich source of medicines, but our ability to explore the full potential of the microbes both in us and around us has been limited by technology and the difficulty of culturing most microbes in a lab. Biosortia Microbiomics has developed a platform for finding, amplifying, and screening microbes as a potential source of novel, small molecule drugs. We spoke to Ross Youngs, CEO and founder of Biosortia, about the case for exploring various microbiomes to discover new small molecule drugs, how the company’s platform technology enables it to investigate a much broader range of microbes, and its business model for capitalizing on the discoveries it makes.

PODCAST: 12/22/2022

In this episode of Life Science Success, my guest is Ross Youngs. Ross is the CEO and Founder of Biosortia Pharmaceutical. Ross is working to Provide previously unobtainable drug-like small molecules directly from microbiomes.

LinkedIn

PODCAST: 11/20/2022

E016: Scaling and breakthrough with Ross Youngs

In this episode, Artur and Marian discuss what is required for scaling technologies and how to achieve breakthroughs. To give a practical example, they interview Ross Youngs, CEO, and founder of Biosortia, who describes his company’s scaling and breakthrough in the field of microbiome harvesting.

You can find out more about Biosortia Microbiomics here – https://biosortia.com/

This podcast is also available on https://bdr.show and your favorite podcast platforms. Subscribe today to make sure you don’t miss any future episodes!

If you’d like to contact us with comments, suggestions, or complaints, email us at po*****@co*******.llc

Enjoy!

PODCAST: 11/03/2022

Master Strategic Change – Focus on Culture and Behavior

Culture & Innovation: Mining the Human Microbiome- Accelerating Research & Discovery

Join me and Ross Youngs, a successful innovator, serial entrepreneur, and the founder and CEO of Biosortia, Inc. – Microbiomics, for great insights on how AI and technology support academia, accelerate discovery, and what this means for humanity.

Apple: https://bit.ly/3hc6fSv
Spotify: https://spoti.fi/3h8U8G1
Buzzsprout: https://bit.ly/3UmW8IX
Podcast: https://bit.ly/3UmW8IX

VIDEO: 10/07/2022

Translating Knowledge from Human Microbiome Technology to the Plant Microbiome.

Ross’s presentation to Future AG Sustainable Goals- Sept 20-21- Hilton San Diego Mission Valley.

PODCAST: 07/12/2022

Innovation is what sets market leaders ahead, but most business owners view it as a luxury. It can feel like your day-to-day responsibilities are too demanding to focus on innovation.

If you want to succeed, you need to start with an innovative strategy that solves problems for your customers and for you. Our guest today can help you do just that.

PODCAST: 09/27/2021

Interview of Microbiome Power with Ross Youngs, CEO of the Biosortia Microbiomics.

Biosortia Microbiomics is developing genuinely disruptive technology for the mining of microbiomes. It was our great pleasure to have the opportunity for an interview with Mr. Ross Youngs, Founder, and CEO of Biosortia.

PODCAST: 09/09/2021

Owner Interview: Disruptive Innovation Isn’t Just for Big Business with Ross Youngs The Revenue Throughput Podcast || Episode 53.

Today’s guest is Ross Youngs, CEO of Univenture and a long-time entrepreneur. He has successfully taken businesses from small investments to hundreds of millions of dollars in revenue. Today’s we will be talking about disruptive innovation and how it’s not a game that is only for the biggest companies like Microsoft or Apple but is actually something you can follow with a couple of key steps.

Ross has spent over 30 years inventing products, technologies, and processes for a variety of industries, and holds over 75 patents worldwide. He is driven to innovate by a focus on what is better, faster, and less expensive.

Ross’ recent major innovations include an R&D 100 Award for collaboration on biopolymer technologies. In 2009, Biosortia was awarded a $6 million ARPA-E grant for its algal harvesting technology, which helped lead to the development of Biosortia’s drug discovery platform.

After listening to today’s episode, check out https://www.biosortia.com/ to learn more about Ross Youngs and Biosortia.

VIDEO: 02/26/2021

Rock Stars of R&D, Episode 29, Ross Youngs

An Engineering Entrepreneur in Technology and now as CEO of BIOSORTIA, Microbiomes, and Microbiomics, Ross spent a career driving breakthrough technologies to fruition and acceptance.

VIDEO: 02/10/2021

Ross Youngs’ presentation during the “Innovation Spotlight" Segment of the meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB).

VIDEO: 09/25/2020

Jesse McLaughlin & Ross Youngs.In the world of drug discovery, for the most part, it hasn’t changed much in decades. Ross Youngs, CEO of Biosortia Pharmaceuticals is looking to change that with a better understanding of the microbiome.

PODCAST: 09/24/2020

Through an interesting turn of events, Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities, they are able to extrapolate this into drug discovery. Ross believes that Biosortia’s ability to mine microbiome on such a large scale will change drug discovery in the coming years.

PODCAST: 08/05/2020

Delighted to share Episode 1, Season 1 of The Sophia Consulting Firm’s “Amplifying Scientific Innovation #Podcast" with Ross Youngs, Founder, and CEO, Biosortia Pharmaceuticals.

PODCAST: 04/02/2020

Ross Youngs has spent over 30 years inventing products, technologies, and processes for a variety of industries, and holds over 75 patents worldwide. He is driven to innovate by a focus on what is better, faster, and less expensive. Ross’ recent major innovations include an R&D 100 Award for collaboration on biopolymer technologies. In 2009, Biosortia was awarded a $6 million ARPA-E (U.S. Dept. of Energy R&D) grant for its algal harvesting technology, which helped lead to the development of Biosortia’s drug discovery platform.

VIDEO: 09/16/2019

Biosortia Pharmaceutical Presentation.

Enabling new, faster, and less expensive drug discovery through unprecedented access to microbiome chemistry.

VIDEO: 07/12/2019

The Donna Drake Show Live It Up with Ross O Youngs on Biosortia Pharmaceutical.

Extract Value from Natural and Chemically Modified Compounds.

Pre-clinical portfolio of microbiome-derived immune-modulating peptides and other small molecules with exclusive technologies and the scientific expertise for discovering, expanding, and advancing a valuable IO/I pipeline.